Eslicarbazepine acetate: a well-kept secret?
- PMID: 20126330
- PMCID: PMC2812714
- DOI: 10.1111/j.1535-7511.2009.01337.x
Eslicarbazepine acetate: a well-kept secret?
Comment on
-
Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.Epilepsia. 2009 Mar;50(3):454-63. doi: 10.1111/j.1528-1167.2008.01946.x. Epub 2009 Feb 21. Epilepsia. 2009. PMID: 19243424 Clinical Trial.
References
-
- EPAR EMEA Zebinix. Document H-988-en6 eslicarbazepine acetate, scientific discussion in the public assessment report for Zebinix (eslicarbazepine acetate INN) http://www.emea.europa.eu/humandocs/Humans/EPAR/zebinix/zebinix.htm.
-
- Benes J, Parada A, Figueiredo AA, Alves PC, Freitas AP, Learmonth DA, Cunha RA, Garrett J, Soares-da-Silva P. Anticonvulsant and sodium channel-blocking properties of novel 10,11- dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives. J Med Chem. 1999;42:2582–2587. - PubMed
-
- Almeida L, Potgieter JH, Maia J, Potgieter MA, Mota F, Soares-da-Silva P. Pharmacokinetics of eslicarbamazepine acetate in patients with moderate hepatic impairment. Eur J Clin Pharmacol. 2008;64:267–273. - PubMed
-
- Elger C, Bialer M, Cramer JA, Maia J, Almeida L, Soares-da-Silva O. Eslicarbazepine acetate: A double-blind, add-on, placebo controlled exploratory trial in adult patients with partial-onset seizures. Epilesia. 2007;48:497–504. - PubMed
-
- Ortenzi A, Paggi A, Foschi N, Sabbatini D, Pistoli E. Oxcarbazepine and adverse events: Impact of age, dosage, metabolite serum concentrations and concomitant antiepileptic therapy. Funct Neurol. 2008;23:97–100. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
